$DXCM News
Last published 1d ago
- 1d agoDXCMDexcom Announces Upcoming Conference PresentationBusiness WireSAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the Jefferies Global Healthcare Conference in London on Tuesday, November 17, 2026.The live presentation is scheduled to begin at approximately 2:00 PM GMT (9:00 AM EST) and will be concurrently webcast.Links to the webcast will be available on the Dexcom Investor Relatio ...
- 1w agoDXCMDEXCOM INC - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 8.01 Item 9.01
- 1w agoDXCMDexcom Reports Third Quarter 2026 Financial ResultsBusiness WireDexCom, Inc. (NASDAQ:DXCM) today reported its financial results as of and for the quarter ended September 30, 2026. Third Quarter 2026 Financial Highlights: Revenue grew 11% year-over-year to $1.344 billion on a
- 2w agoDXCMDexcom G7 15 Day Continuous Glucose Monitoring System to Launch in Canada in NovemberBusiness WireThe longest-lasting and most accurate1 continuous glucose monitoring (CGM) system authorized by Health Canada will offer people living with diabetes over the age of 18 up to 15.5 days of wear with fewer sensor
- 2w agoDXCMDid DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders?PR NewswireShareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket
- 4w agoDXCMLandmark Dexcom CONNECT Study Published in The New England Journal of Medicine, Redefining the Standard of Care for People with Type 2 Diabetes Not on InsulinBusiness WirePublication marks the first time in nearly two decades that The New England Journal of Medicine has published clinical data on standalone real-time continuous glucose monitoring (CGM) technology, dating back to the
- 1mo agoDXCMDexcom Schedules Third Quarter 2026 Earnings Release and Conference Call for October 29, 2026 at 4:30 p.m. Eastern TimeBusiness WireDexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2026 financial results after market close on Thursday, October 29, 2026. Management will hold a conference call to review the
- 1mo agoDXCMDexcom U Enters Season 5 With a Record Roster and Evidence That Diabetes Stigma Among Young Athletes Is FadingBusiness WireFirst-of-its-kind NIL program features 27 athletes with Type 1 diabetes across 13 sports, marking the program’s largest roster to dateDexcom will host "Dexcom U Days" this fall to drive meaningful community and
- 1mo agoDXCMDexcom Publishes New Report During EASD 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes CareBusiness WireNew global State of Type 2 Report uncovers three interconnected challenges in Type 2 diabetes care: health literacy, technology literacy and systemic access.1 New partnership reinforces Dexcom’s commitment to
- 1mo agoDXCMDexcom Promotes Jereme Sylvain to Chief Operating OfficerBusiness WireDexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, today announced the promotion of Jereme Sylvain to the role of Chief Operating Officer (COO) in addition to his duties as Chief Financial Officer. In
- 2mo agoDXCMDexcom Appoints Glenn Boehnlein to Board of DirectorsBusiness WireDexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, today announced the appointment of Glenn Boehnlein to its Board of Directors, effective September 10, 2026. Mr. Boehnlein is a highly accomplished
- 2mo agoDXCMWELLS FARGO 21ST ANNUAL HEALTHCARE CONFERENCE - DEXCOM INCEarnings Call TranscriptsOkay. All right. Welcome back to day two of the 2026 Wells Fargo Healthcare Conference. I'm Larry Beagleson, the MedTech Analyst, and it's my pleasure to host this fireside chat with the management from Dexcom. With us,
- 2mo agoDXCMDexcom Announces Upcoming Conference PresentationBusiness WireDexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026. The live presentation is
- 2mo agoDXCM005930.KSOura is reportedly eyeing a September IPO that could value it at more than $16BTechCrunch
- 3mo agoDXCMDexcom Reports Second Quarter 2026 Financial ResultsBusiness WireDexCom, Inc. (NASDAQ:DXCM) today reported its financial results as of and for the quarter ended June 30, 2026. Second Quarter 2026 Financial Highlights: Revenue grew 13% year-over-year to $1.308 billion on a
- 3mo agoDXCMDexcom Announced as First Participant Selected for FDA's TEMPO Digital Health Devices Pilot ProgramBusiness WireParticipation advances the company’s vision and regulatory pathway for earlier intervention, screening for prediabetes and Type 2 diabetes and empowerment Dexcom (NASDAQ:DXCM), the global leader in glucose
- 3mo agoDXCMCMSFDA Announces First Participant Selected for TEMPO for Digital Health Devices PilotFDA Press ReleasesThe U.S. Food and Drug Administration today announced the first manufacturer selected for the Technology-Enabled Meaningful Patient Outcomes (TEMPO) for Digital Health Devices Pilot. The participating manufacturer intends to offer a device for use in providing care expected to be covered by the Centers for Medicare & Medicaid Services (CMS) Innovation Center’s ACCESS (Advancing Chronic Care with E ...
- 4mo agoDXCMDexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with DiabetesBusiness WireDexcom G7 15 Day is the longest‑lasting and most accurate1-4 CGM system authorized by Health Canada, providing real-time glucose readings for an industry-leading 15.5 days5. Dexcom, Inc. (NASDAQ:DXCM), the global
- 4mo agoDXCMDexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 p.m. Eastern TimeBusiness WireDexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2026 financial results after market close on Thursday, July 30, 2026. Management will hold a conference call to review the
- 4mo agoDXCMDexcom Further Advances Vision of Glucose Biosensing for AllBusiness WireAt Aspen Ideas: Health, Dexcom announced regulatory milestones, including pediatric clearance for Stelo, further advancing access to glucose biosensing in the United States.The company also announced details regarding
- 5mo agoDXCMFDA Clears First Over-the-Counter Continuous Glucose Monitor for ChildrenFDA Press ReleasesThe U.S. Food and Drug Administration today cleared for marketing the first over-the-counter (OTC) continuous glucose monitor (CGM) for children, Dexcom Inc.’s Stelo Glucose Biosensor System, an integrated CGM (iCGM) indicated for people two years of age and older who do not use insulin. The FDA previously cleared the Stelo Glucose Biosensor System OTC for individuals 18 years and older in March 2 ...
- 5mo agoDXCMDexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using InsulinBusiness WireDexcom sponsored CONNECT randomized controlled trial expected to help establish new standard of care for CGM use by people with Type 2 diabetes not using insulin around the world. Showed use of Dexcom G7 led to
- 5mo agoDXCMDexcom Reaffirms CGM Benefits for All People With Diabetes and Continues Momentum Toward Earlier Stage Intervention and Preventative Care at ADA 2026Business WireHighly anticipated presentation of results from the CONNECT randomized control trial will be presented during the ADA Scientific Sessions conference on Saturday, June 6 at 1:45 p.m. CDT. Early access launch of a
- 5mo agoDXCMDexcom Releases Customer Advisory Council Report, Outlining Ongoing Commitments to Enhancing Product Performance and User ExperienceBusiness WireCompany establishes permanent council to drive ongoing innovation guided by community feedback Report outlines targeted commitments Dexcom is making to address sentiments shared by council members Dexcom, Inc.,
- 5mo agoDXCM.DJISNOWAMZN+3U.S.-Iran strikes, Snowflake soars, Robinhood's new AI tools and more in Morning SquawkCNBCHere are five key things investors need to know to start the trading day.
- 5mo agoDXCMGOOGLNVOLLY+1Signos grows foothold in weight-loss wave fueled by GLP-1s with its AI health data trackingCNBCHealth tech startup Signos announced a $20 million funding round Wednesday, including an expanded partnership with medical device giant Dexcom.
- 5mo agoDXCMDexcom Uncovers Theft of Scrapped Product, Notifies Potentially Impacted UsersBusiness WireThrough ongoing quality and accounting reviews, Dexcom discovered two lots of scrapped product were stolen by a third party before destruction and sold into the market. Dexcom is working closely with the FDA and
- 5mo agoDXCMRedefining CGM for People With Type 2 Diabetes: Dexcom Announces Dexcom Flex in GermanyBusiness WireDexcom has announced a new continuous glucose monitoring system designed for people using basal insulin, oral therapies or GLP-1 receptor agonists1. The new system will be available shortly. Dexcom Flex provides
- 6mo agoDXCMDexcom Announces Governance Enhancements Ahead of 2026 Investor DayBusiness WireWill Add Two Independent Directors with MedTech and Operations Experience to be Named at a Later Date Reconstituted Operations and Innovation Committee Will Expand Mandate to Oversee Operations, Quality and Technical
- 6mo agoDXCMDexcom to Host Investor Day on May 14, 2026Business WireDexCom, Inc. (NASDAQ:DXCM) today announced that it will host an Investor Day on Thursday, May 14, 2026 from 1:15 PM until approximately 3:30 PM PDT (4:15 PM – 6:30 PM EDT). The event will include presentations from
- 6mo agoDXCMDexCom, Inc. First Quarter 2026 Earnings Release Conference CallDEXCOM INCEarnings Call TranscriptsLadies and gentlemen, welcome to the Dexcom first quarter 2026 earnings release conference call. My name is Abby and I will be your operator for today's call. At this time, all participants are in a listen-only mode. Lat
- 6mo agoDXCMDexcom Reports First Quarter 2026 Financial ResultsBusiness WireDexCom, Inc. (NASDAQ:DXCM) today reported its financial results as of and for the quarter ended March 31, 2026. First Quarter 2026 Financial Highlights: Revenue grew 15% year-over-year to $1.192 billion on a
- 6mo agoMDTDHRPROFDXCMWhy Medtech Giants Are Quietly Paying Up for AI DiagnosticsPR NewswireUSANewsGroup.com News Commentary – There's a quiet bidding war underway for AI diagnostics, and the price keeps climbing. The global AI in medical...
- 7mo agoDXCMDexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4:30 p.m. Eastern TimeBusiness WireDexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2026 financial results after market close on Thursday, April 30, 2026. Management will hold a conference call to review the
- 8mo agoDXCMDexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026Business WireNew registry study data shows that long-term use of Dexcom G7 supports weight management and lowers A1C for people with Type 2 diabetes who aren't on insulin therapy1, reinforcing the need to broaden CGM access beyond
- 8mo agoDXCMDexcom Appoints Rick Osterloh to Board of DirectorsBusiness WireDexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, today announced the appointment of Rick Osterloh to its Board of Directors, effective February 26, 2026. Mr. Osterloh is a highly accomplished
- 8mo agoDXCMDexcom Announces Upcoming Conference PresentationBusiness WireDexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the 47th Annual Raymond James Institutional Investors Conference on Monday, March 2, 2026. The live presentation is
- 9mo agoDXCMDexCom, Inc. Fourth Quarter 2025 Earnings Release Conference CallDEXCOM INCEarnings Call TranscriptsLadies and gentlemen, good afternoon and welcome to the Dexcom 4th Quarter and Fiscal Year 2025 Earnings Release Conference Call. My name is Abby and I will be your operator today. At this time, all participants are in a
- 9mo agoDXCMDexcom Reports Fourth Quarter and Fiscal Year 2025 Financial ResultsBusiness WireDexCom, Inc. (NASDAQ:DXCM) today reported its financial results as of and for the quarter and fiscal year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights: Revenue grew 13% year-over-year to $1.260
- 9mo agoDXCMStelo Adds Enhanced Smart Meal Logging Features as Dexcom Continues to Transform Personal Glucose ManagementBusiness WireEnhanced Smart Food Logging experience now provides nutritional breakdown of meals Advanced AI-enabled features will deliver easy meal tracking to transform daily metabolic health management Redesigned and
- 10mo agoDXCMDexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 OutlookBusiness WireDexCom, Inc. (NASDAQ:DXCM) today reported preliminary, unaudited results for the fourth quarter ended December 31, 2025 with total revenue of approximately $1.260 billion, an increase of 13% over the fourth quarter of
- 10mo agoDXCMDexCom, Inc. - Appeal, AffirmedUS Patent Trial and Appeal Board
- 10mo agoDXCMDexCom, Inc. - Appeal, AffirmedUS Patent Trial and Appeal Board
- 10mo agoDXCMThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom, Inc. Lawsuit – DXCMGlobeNewswireNEW YORK, Dec. 22, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of DexCom, Inc. (NASDAQ:DXCM). Shareholders who purchased shares of DXCM during the class period listed are
- 10mo agoDXCMDexCom, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - DXCMPR NewswireThe Gross Law Firm issues the following notice to shareholders of DexCom, Inc. (NASDAQ: DXCM). Shareholders who purchased shares of DXCM during the...
- 10mo agoDXCMDexCom, Inc. - Appeal, AffirmedUS Patent Trial and Appeal Board
- 11mo agoDXCMDexCom, Inc. - Appeal, ReversedUS Patent Trial and Appeal Board
- 11mo agoDXCMDexCom, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before December 26, 2025 to Discuss Your Rights – DXCMGlobeNewswireNEW YORK, Dec. 11, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of DexCom, Inc. (NASDAQ:DXCM). Shareholders who purchased shares of DXCM during the class period listed are
- 11mo agoDXCMThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom, Inc. Lawsuit - DXCMPR NewswireThe Gross Law Firm issues the following notice to shareholders of DexCom, Inc. (NASDAQ: DXCM). Shareholders who purchased shares of DXCM during the...
- 11mo agoDXCMDexCom, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before December 26, 2025 to Discuss Your Rights - DXCMPR NewswireThe Gross Law Firm issues the following notice to shareholders of DexCom, Inc. (NASDAQ: DXCM). Shareholders who purchased shares of DXCM during the...